Organotypic Models in Drug Development

Organotypic Models in Drug Development

Landsiedel, Robert; Stuchi Maria-Engler, Silvya; Schaefer-Korting, Monika

Springer Nature Switzerland AG

03/2022

323

Mole

Inglês

9783030700652

15 a 20 dias

603

Descrição não disponível.
Inflammatory skin disease models in vitro and in animals - predictability for drug development.- Neural In Vitro Models for Studying Substances Acting on the Central Nervous System.- Quality of commercial tissues Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development.- Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh.- Disease Models: Lung models for testing drugs against inflammation and infection.- In Vitro Models of the Blood-Brain Barrier.- How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development.- The CAM Assay as an Alternative In Vivo Model for Drug Testing.- Organotypic Models in Drug Development "Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development.- Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling.- Immunocompetent human intestinal models in preclinical drug development.- EngineeredHeart Muscle Models in Phenotypic Drug Screens.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
organotypic models in drug development;human-based test systems;disease models;3D organ cultures;human-derived specimens;gene therapy